title: Intrathecal baclofen in the management of spasticity due to cerebral palsy.
abstract: Intrathecal baclofen is a cornerstone in the treatment of spasticity in children. However, further research is required to set criteria for treatment. This paper offers insight into the national act on baclofen and the experience at the Nottingham University Hospital.
authors.affiliation: Queens Medical Centre, Nottingham, UK. Michael.vloeberghs@nottingham.ac.uk
authors.forename: Michael
authors.initials: M
authors.lastname: Vloeberghs
authors.forename: Rachel
authors.initials: R
authors.lastname: Keetley
authors.forename: Richard
authors.initials: R
authors.lastname: Morton
mesh_terms: D001418:Baclofen / Q000008:administration & dosage / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000517:prevention & control*; D002648:Child; D006801:Humans; D015918:Infusion Pumps, Implantable; D007278:Injections, Spinal; D009125:Muscle Relaxants, Central / Q000008:administration & dosage / Q000627:therapeutic use*; D009128:Muscle Spasticity / Q000517:prevention & control
chemical_list: D009125:Muscle Relaxants, Central; D001418:Baclofen